Rofecoxib is a COX-2 selective nonsteroidal anti-inflammatory drug (NSAID). It was marketed by Merck & Co. to treat osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis, acute pain conditions, migraine, and dysmenorrhea.Rofecoxib was available by prescription in both tablet-form and as an oral suspension.
This report contains market size and forecasts of Rofecoxib in global, including the following market information:
Global Rofecoxib Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Rofecoxib Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Rofecoxib companies in 2021 (%)
The global Rofecoxib market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Suspension. Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Rofecoxib include Merck, Chengdu Meinkai Chemical Co. LTD, Wuhan Xinxin Jiali Biotechnology Co. LTD, Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD, Pfizer and Tremeau, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Rofecoxib manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rofecoxib Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Rofecoxib Market Segment Percentages, by Type, 2021 (%)
Oral Suspension.
Tablet-Form
Global Rofecoxib Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Rofecoxib Market Segment Percentages, by Application, 2021 (%)
Osteoarthritis
Rheumatoid Arthritis
Juvenile Rheumatoid Arthritis
Acute Pain Conditions
Migraine
Dysmenorrhea
Global Rofecoxib Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Rofecoxib Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Rofecoxib revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Rofecoxib revenues share in global market, 2021 (%)
Key companies Rofecoxib sales in global market, 2017-2022 (Estimated), (MT)
Key companies Rofecoxib sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Chengdu Meinkai Chemical Co. LTD
Wuhan Xinxin Jiali Biotechnology Co. LTD
Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
Pfizer
Tremeau